Beatrice Gini, Ph.D.
Affiliations: | Molecular Pathology | Ludwig Institute for Cancer Research, San Diego, CA, United States |
Website:
http://www.ludwigsd.org/labs/molecular_pathology/people/Google:
"Beatrice Gini"Mean distance: 30533.1
Cross-listing: Chemistry Tree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Caswell DR, Gui P, Mayekar MK, et al. (2023) The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance. Nature Genetics |
| Gini B, Thomas N, Blakely CM. (2020) Impact of concurrent genomic alterations in epidermal growth factor receptor ()-mutated lung cancer. Journal of Thoracic Disease. 12: 2883-2895 |
| Blakely CM, Watkins TBK, Wu W, et al. (2017) Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers. Nature Genetics |
| Gu Y, Albuquerque CP, Braas D, et al. (2017) mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT. Molecular Cell |
| Okimoto RA, Breitenbuecher F, Olivas VR, et al. (2016) Inactivation of Capicua drives cancer metastasis. Nature Genetics |
| Wei W, Shin YS, Xue M, et al. (2016) Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in Glioblastoma. Cancer Cell. 29: 563-73 |
| Tanaka K, Sasayama T, Irino Y, et al. (2015) Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment. The Journal of Clinical Investigation. 125: 1591-602 |
| Shin YS, Wei W, Gini B, et al. (2015) Abstract PR09: Single cell phosphoproteomics identifies adaptive network dynamics of mTOR inhibitor resistance and defines effective combination therapy in glioblastoma Clinical Cancer Research. 21 |
| Gini B, Mischel PS. (2014) Greater than the sum of its parts: single-nucleus sequencing identifies convergent evolution of independent EGFR mutants in GBM. Cancer Discovery. 4: 876-8 |
| Nathanson DA, Gini B, Mottahedeh J, et al. (2014) Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA. Science (New York, N.Y.). 343: 72-6 |